HK1203370A1 - Method for treatment of labor arrest - Google Patents
Method for treatment of labor arrest Download PDFInfo
- Publication number
- HK1203370A1 HK1203370A1 HK15103909.7A HK15103909A HK1203370A1 HK 1203370 A1 HK1203370 A1 HK 1203370A1 HK 15103909 A HK15103909 A HK 15103909A HK 1203370 A1 HK1203370 A1 HK 1203370A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- labor
- arrest
- labor arrest
- sulfated glycosaminoglycans
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/095—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261615400P | 2012-03-26 | 2012-03-26 | |
| US61/615,400 | 2012-03-26 | ||
| PCT/SE2013/050333 WO2013147690A1 (en) | 2012-03-26 | 2013-03-25 | Method for treatment of labor arrest |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1203370A1 true HK1203370A1 (en) | 2015-10-30 |
Family
ID=49260784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK15103909.7A HK1203370A1 (en) | 2012-03-26 | 2013-03-25 | Method for treatment of labor arrest |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20150057226A1 (enExample) |
| EP (1) | EP2830634A4 (enExample) |
| JP (1) | JP2015514705A (enExample) |
| CN (1) | CN104244957B (enExample) |
| AU (1) | AU2013240598A1 (enExample) |
| CA (1) | CA2868479A1 (enExample) |
| HK (1) | HK1203370A1 (enExample) |
| MX (1) | MX2014011451A (enExample) |
| MY (1) | MY185108A (enExample) |
| NZ (1) | NZ631279A (enExample) |
| RU (1) | RU2014143008A (enExample) |
| SG (1) | SG11201406118QA (enExample) |
| UA (1) | UA117907C2 (enExample) |
| WO (1) | WO2013147690A1 (enExample) |
| ZA (1) | ZA201406567B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013095215A1 (en) | 2011-12-19 | 2013-06-27 | Dilaforette Ab | Low anticoagulant heparins |
| SMT201800143T1 (it) | 2011-12-19 | 2018-05-02 | Dilafor Ab | Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico |
| SG10201607872PA (en) | 2012-03-26 | 2016-11-29 | Santen Pharmaceutical Co Ltd | Ophthalmic solution comprising diquafosol |
| CA2868403A1 (en) * | 2012-05-08 | 2013-11-14 | Dilafor Ab | Treatment of postpartum haemorrhage with chemically modified heparin or heparan sulphate and a uterotonic agent |
| KR20220142508A (ko) | 2020-02-17 | 2022-10-21 | 딜라포 아베 | 자간전증 치료용 타폭시파린 |
| CA3255831A1 (en) | 2022-05-03 | 2023-11-09 | Dilafor Ab | NEW MEDICAL USE OF TAFOXIPARIN |
| EP4272749A1 (en) | 2022-05-03 | 2023-11-08 | Dilafor AB | New medical use of tafoxiparin |
| AU2024213271A1 (en) * | 2023-02-01 | 2025-07-17 | Materna Medical, Inc. | Methods and apparatus for preventing vaginal lacerations during childbirth |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000065837A (ja) * | 1998-08-24 | 2000-03-03 | Seikagaku Kogyo Co Ltd | グリコサミノグリカン又はグリコサミノグリカン結合性分子の測定方法及びその測定用キット |
| JP2000309544A (ja) * | 1999-02-25 | 2000-11-07 | Seikagaku Kogyo Co Ltd | 早産または流産防止剤および子宮頚管熟化抑制剤ならびにヒアルロニダーゼの阻害剤 |
| SE521676C2 (sv) * | 2002-01-02 | 2003-11-25 | Dilafor Ab | Användning av glykosaminoglykaner för prevention och behandling av värksvaghet vid fullgången graviditet |
| US8445436B2 (en) * | 2007-12-03 | 2013-05-21 | Florida State University Research Foundation, Inc. | Oxytocin and melatonin compositions and associated methods for inducing labor |
| SMT201800143T1 (it) * | 2011-12-19 | 2018-05-02 | Dilafor Ab | Glicosaminoglicani non anticoagulanti comprendenti un'unita ripetitiva di disaccaridi e loro uso medico |
-
2013
- 2013-03-25 SG SG11201406118QA patent/SG11201406118QA/en unknown
- 2013-03-25 HK HK15103909.7A patent/HK1203370A1/xx unknown
- 2013-03-25 UA UAA201411545A patent/UA117907C2/uk unknown
- 2013-03-25 WO PCT/SE2013/050333 patent/WO2013147690A1/en not_active Ceased
- 2013-03-25 RU RU2014143008A patent/RU2014143008A/ru not_active Application Discontinuation
- 2013-03-25 CA CA2868479A patent/CA2868479A1/en not_active Abandoned
- 2013-03-25 MX MX2014011451A patent/MX2014011451A/es unknown
- 2013-03-25 AU AU2013240598A patent/AU2013240598A1/en not_active Abandoned
- 2013-03-25 MY MYPI2014002744A patent/MY185108A/en unknown
- 2013-03-25 CN CN201380016529.6A patent/CN104244957B/zh active Active
- 2013-03-25 EP EP13768034.4A patent/EP2830634A4/en not_active Withdrawn
- 2013-03-25 US US14/387,929 patent/US20150057226A1/en not_active Abandoned
- 2013-03-25 NZ NZ631279A patent/NZ631279A/en unknown
- 2013-03-25 JP JP2015503159A patent/JP2015514705A/ja active Pending
-
2014
- 2014-09-08 ZA ZA2014/06567A patent/ZA201406567B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2013240598A1 (en) | 2014-10-02 |
| CA2868479A1 (en) | 2013-10-03 |
| SG11201406118QA (en) | 2014-11-27 |
| WO2013147690A1 (en) | 2013-10-03 |
| MX2014011451A (es) | 2014-11-10 |
| EP2830634A1 (en) | 2015-02-04 |
| NZ631279A (en) | 2016-06-24 |
| JP2015514705A (ja) | 2015-05-21 |
| MY185108A (en) | 2021-04-30 |
| CN104244957A (zh) | 2014-12-24 |
| CN104244957B (zh) | 2017-11-17 |
| ZA201406567B (en) | 2017-06-28 |
| US20150057226A1 (en) | 2015-02-26 |
| RU2014143008A (ru) | 2016-05-20 |
| UA117907C2 (uk) | 2018-10-25 |
| EP2830634A4 (en) | 2016-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1203370A1 (en) | Method for treatment of labor arrest | |
| IL231536A (en) | Indazole-3-carboxamides, pharmaceuticals containing them and their use in the treatment of diseases | |
| WO2015003360A3 (en) | Therapeutically active compounds and their methods of use | |
| HK1203356A1 (en) | Pharmaceutical combinations comprising a thionucleotide analog | |
| SG11201407162SA (en) | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | |
| EP2822598A4 (en) | POLYMERS HAVING THERAPEUTICALLY ACTIVE AGENTS CONJUGATED THERETO, METHODS FOR THE PREPARATION OF SAID POLYMERS AND USES THEREOF | |
| IL237649A0 (en) | Diagnosis, prevention and treatment of joint diseases | |
| WO2012121977A3 (en) | Dodecafluoropentane emulsion as a stroke and ischemia therapy | |
| HK1223924A1 (zh) | 治疗活性化合物及其使用方法 | |
| IL238800B (en) | Immunomodulatory compounds and drugs containing them for use in the treatment of allergic diseases and other inflammatory conditions, infectious diseases and cancer | |
| WO2013117744A3 (en) | Methods of treating fibrosis | |
| WO2013185764A3 (en) | Pharmaceutical compositions for combination therapy | |
| WO2014153009A3 (en) | Thiosaccharide mucolytic agents | |
| EP3318879A4 (en) | Gpc3-targeted therapeutic agent administered to patient in whom gpc3-targetd therapeutic ag | |
| GB2497453B8 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
| CL2013003700A1 (es) | Composicion farmaceutica oftalmologica topica que comprende regorafenib, el cual se encuentra suspendido en un vehiculo farmaceuticamente aceptable; procedimiento de fabricacion y su uso para tratar o prevenir un trastorno oftalmologico. | |
| HK1203369A1 (en) | Combination treatment comprising sulphated glycosaminoglycans for inducing labor | |
| IL236637A (en) | Diploorulctam Compounds as selective ep4 receptor agonists for use in ep4-mediated diseases and conditions | |
| EP2818154A4 (en) | TOPICAL PREPARATION FOR SKIN AND CELL ACTIVATION AGENT FOR HEALTHY SKIN | |
| EP3265060A4 (en) | Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent | |
| SI3125865T1 (sl) | Povezava aktivnih sestavin za lokalno uporabo pri prestrukturiranju spremenjene kožne pregrade ki sledi kožnim boleznim | |
| WO2015063613A3 (en) | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents | |
| WO2013176877A3 (en) | Treatment of addiction and impulse-control disorders using pde7 inhibitors | |
| IN2014MN02461A (enExample) | ||
| MY192330A (en) | Treatment of postpartum haemorrhage with chemically modified heapin or heparan sulphate and a uterotonic agent |